Adial Pharmaceuticals Secures Strategic Manufacturing Partnerships

Adial Pharmaceuticals shares are trading higher after announcing U.S.-based manufacturing agreements with Cambrex and Thermo Fisher Scientific to support clinical trials and their New Drug Application for AD04.